000			01773 a2200529 4500
005			20250517203100.0
264		0	_c20181105
008			201811s 0 0 eng d
022			_a1873-7064
024	7		_a10.1016/j.neuropharm.2018.02.022 _2doi
040			_aNLM _beng _cNLM
100	1		_aCrivello, Martin
245	0	0	_aPleiotropic activity of systemically delivered angiogenin in the SOD1 _h[electronic resource]
260			_bNeuropharmacology _c05 2018
300			_a503-511 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAge Factors
650	0	4	_aAmyotrophic Lateral Sclerosis _xblood
650	0	4	_aAngiogenesis Inducing Agents _xtherapeutic use
650	0	4	_aAnimals
650	0	4	_aAstrocytes _xdrug effects
650	0	4	_aDisease Models, Animal
650	0	4	_aEndothelial Cells _xdrug effects
650	0	4	_aFemale
650	0	4	_aGlial Fibrillary Acidic Protein _xmetabolism
650	0	4	_aHumans
650	0	4	_aMale
650	0	4	_aMice
650	0	4	_aMice, Transgenic
650	0	4	_aMotor Neurons _xdrug effects
650	0	4	_aMovement Disorders _xdrug therapy
650	0	4	_aRibonuclease, Pancreatic _xblood
650	0	4	_aRotarod Performance Test
650	0	4	_aSuperoxide Dismutase _xgenetics
650	0	4	_aSurvival Analysis
650	0	4	_aTime Factors
700	1		_aO'Riordan, Saidhbhe L
700	1		_aWoods, Ina
700	1		_aCannon, Sarah
700	1		_aHalang, Luise
700	1		_aCoughlan, Karen S
700	1		_aHogg, Marion C
700	1		_aLewandowski, Sebastian A
700	1		_aPrehn, Jochen H M
773	0		_tNeuropharmacology _gvol. 133 _gp. 503-511
856	4	0	_uhttps://doi.org/10.1016/j.neuropharm.2018.02.022 _zAvailable from publisher's website
999			_c28127742 _d28127742